ABRAXAS (FAM175A) and breast cancer susceptibility: No evidence of association in the breast cancer family registry

Anne Laure Renault, Fabienne Lesueur, Yan Coulombe, Stéphane Gobeil, Penny Soucy, Yosr Hamdi, Sylvie Desjardins, Florence Le Calvez-Kelm, Maxime Vallée, Catherine Voegele, Breast Cancer Family Registry, John L. Hopper, Irene L. Andrulis, Melissa C. Southey, Esther M. John, Jean Yves Masson, Sean V. Tavtigian, Jacques Simard Simard

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

Approximately half of the familial aggregation of breast cancer remains unexplained. This proportion is less for early-onset disease where familial aggregation is greater, suggesting that other susceptibility genes remain to be discovered. The majority of known breast cancer susceptibility genes are involved in the DNA double-strand break repair pathway. ABRAXAS is involved in this pathway and mutations in this gene impair BRCA1 recruitment to DNA damage foci and increase cell sensitivity to ionizing radiation. Moreover, a recurrent germline mutation was reported in Finnish high-risk breast cancer families. To determine if ABRAXAS could be a breast cancer susceptibility gene in other populations, we conducted a population-based case-control mutation screening study of the coding exons and exon/intron boundaries of ABRAXAS in the Breast Cancer Family Registry. In addition to the common variant p.Asp373Asn, sixteen distinct rare variants were identified. Although no significant difference in allele frequencies between cases and controls was observed for the identified variants, two variants, p.Gly39Val and p.Thr141Ile, were shown to diminish phosphorylation of gamma-H2AX in MCF7 human breast adenocarcinoma cells, an important biomarker of DNA double-strand breaks. Overall, likely damaging or neutral variants were evenly represented among cases and controls suggesting that rare variants in ABRAXAS may explain only a small proportion of hereditary breast cancer.

Original languageEnglish
Article numbere0156820
Number of pages20
JournalPLoS ONE
Volume11
Issue number6
DOIs
Publication statusPublished - 1 Jun 2016
Externally publishedYes

Cite this

Renault, A. L., Lesueur, F., Coulombe, Y., Gobeil, S., Soucy, P., Hamdi, Y., Desjardins, S., Le Calvez-Kelm, F., Vallée, M., Voegele, C., Breast Cancer Family Registry, Hopper, J. L., Andrulis, I. L., Southey, M. C., John, E. M., Masson, J. Y., Tavtigian, S. V., & Simard, J. S. (2016). ABRAXAS (FAM175A) and breast cancer susceptibility: No evidence of association in the breast cancer family registry. PLoS ONE, 11(6), [e0156820]. https://doi.org/10.1371/journal.pone.0156820